Coris Bioconcept diagnoses antibiotic resistance
With almost 20 years of experience, Coris BioConcept knows the world of infectious disease diagnostics inside and out. Their straightforward chromatography-based […]
Multiplicom: a strong focus on DNA analysis
Multiplicom offers molecular diagnostics products, focused on human genetics, oncology and prenatal testing. The company was built on a technology that came from the University of Antwerp and VIB, allowing multiplexing on a very high level. They combined this technology with Next Generation Sequencing (NGS), resulting in convenient and reliable products, enabling a simplified workflow […]
KU Leuven students develop winning device to detect kidney failure
A team of fourteen KU Leuven students has built a diagnostic device that can analyze the blood of kidney patients in five minutes. It’s a fast, inexpensive, portable alternative to the current slow, costly, lab-bound devices. With their design, the students won three prizes at the SensUs competition, an international competition for biosensors in the […]
ADHD, a disorder cured by play
In 2013, a new BioWin project, NeuroAtt, was launched to arrive at a reliable diagnosis for ADHD (Attention Deficit Hyperactivity Disorder) and to find the least […]
The Center of Human Genetics reveals all your secrets
Have a cystic fibrosis or BRCA mutation, or maybe a dangerous variant of the Huntington’s gene dangling in your cells? The Center of Human Genetics (CME) in Leuven will clear this out for you. As the biggest diagnostic unit in Belgium, CME is a major player at the European level in terms of genetic diagnosis. […]
Diagnostics for better use of the healthcare budget
Developing a diagnostic test is one thing. Bringing it to the market while taking into account the product’s value for different stakeholders is a very different task. While clinicians might estimate the value of a test by its impact on the patient, many more factors influence the success of a diagnostic product. All stakeholders, from […]
From Belgium to NYC and starting a ‘super sniffer’ company
Charlotte D’Hulst left Belgium for a postdoc in NYC. Today she has two kids and lives in Brooklyn. Oh, and she founded a biotech company, MouSensor, LLC. Hard to resist the entrepreneurial buzz in NYC… Charlotte moved to the Big Apple for a postdoc position on fragile X syndrome. But she got hooked on the […]
Diagnosis on your smartphone!
Belgium’s first-ever mHealth Hackathon event took place in Brussels between March 18-20, 2016. Armed with breakthrough ideas and backed up by caffeine, competitive technology developers, scientists and medical professionals came together to answer one question: How can we revolutionize disease prevention, diagnosis and treatment in everyday healthcare practice? The Hackathon for mobile health revolution The […]
Precision oncology: shaping a patient-centric approach
OncoDNA was founded only three years ago in Gosselies. Its focus: help the oncologist follow the evolution of a patient’s cancer, collect relevant clinical data on this cancer and create a network for discussion during all phases of the treatment process. “The situation for an oncologist is becoming more and more complex, with more targeted […]
The Year of Biocartis
2015 was a truly eventful year for Biocartis. It was marked by many transitions, which some see as a prelude to the company becoming a globally active market leader. Biocartis saw the source of its income shift from R&D to sales, as it was the first full financial year since the launch of its diagnostic platform Idylla™. In April 2015, the diagnostics producer delivered a stellar IPO, with the demand for Biocartis shares exceeding the availability by 6.5 times. 2016 is already off to a strong start: After recent collaboration deals with industry greats such as Merck and Amgen, Biocartis seems to be well on its way to becoming a force in the diagnostics market.
RSV or the flu? Now you know it immediately
Janssen Diagnostics has developed a molecular diagnostic test which will be used with the Biocartis’ Idylla™ platform, to determine Influenza and Respiratory Syncytial Virus (RSV) infections of the upper respiratory tract. The test was launched recently on November 30th. Patient’s time is precious Time plays a crucial role in determining if a patient is infected […]
Biobanking: a vital asset for Belgium’s scientific excellence
In 2014, three French-speaking universities of Belgium (UCL, ULB, ULg, in association with UMons and UNamur) joined forces, with the support of DG06, Innoviris and BioWin, to create the Biothèque Wallonie Bruxelles (BWB), the network of biobanking entities in the regions of Brussels Capital and Wallonia providing a virtual catalogue of biospecimens covering a large […]
Ebola diagnostics – faster, safer, and more accurate
“Last year the Ebola outbreak kick-started the development of a fast and accurate Ebola test to be used with Biocartis’ Idylla™ platform” – says Daap Kooij (Janssen Diagnostics). “We expect the test developed in partnership with Biocartis to be ready for clinical use by Q4 of 2015 as an FDA approved EUA product. It will […]
Idylla™ : a lab-in-a-box
Janssen and Biocartis are collaborating in order to bring diagnostic testing closer to the patients. To learn more about the future objectives of the Janssen – Biocartis partnership we are talking with Daap Kooij, the Global Business Leader at Janssen Diagnostics, a Medical Biologist who also holds an MBA. Based on recent scientific findings, doctors […]
Nuclear technology saves lives, especially in Belgium!
Nuclear energy has become a part of our every day lives, but not solely for electricity production. Over the last century, nuclear technology has become increasingly important in health care. It all started with X-ray imaging, but was quickly followed by Single Photon Emission Tomography (SPECT) and later Positron Emission Tomography (PET). In addition to […]